In a model of hepato-schistosomiasis-induced fibrosis, recombinant BMP7 reduced histopathological features of fibrotic lesion and diminished TGF-β1 and αSMA expression in liver, results that again suggest that BMP7-antifibrotic effects might be dependent on its action on the TGF-β pathway [111]. This evidence concerns the gene TGFB1 and schistosomiasis.